Streetbeat News

Analyst Ratings

AMTB

Stephens & Co. has upgraded Amerant Bancorp (NYSE:AMTB) from Equal-Weight to Overweight and increased the price target from $24 to $25.

Portfolio Pulse from Benzinga Newsdesk

September 30, 2024 | 3:40 pm

SHW

BMO Capital has maintained its 'Outperform' rating on Sherwin-Williams and increased the price target from $400 to $425, indicating confidence in the company's future performance.

Portfolio Pulse from Benzinga Newsdesk

September 30, 2024 | 3:40 pm

NGVT

BMO Capital analyst John McNulty has maintained a Market Perform rating on Ingevity (NYSE:NGVT) while lowering the price target from $42 to $40.

Portfolio Pulse from Benzinga Newsdesk

September 30, 2024 | 3:37 pm

HXL

BMO Capital analyst John McNulty maintains a Market Perform rating on Hexcel (NYSE:HXL) but lowers the price target from $71 to $70.

Portfolio Pulse from Benzinga Newsdesk

September 30, 2024 | 3:34 pm

ECL

BMO Capital analyst John McNulty maintains a Market Perform rating on Ecolab (NYSE:ECL) and raises the price target from $234 to $260.

Portfolio Pulse from Benzinga Newsdesk

September 30, 2024 | 3:31 pm

DTC

Canaccord Genuity analyst Brian McNamara has reiterated a Buy rating for Solo Brands (NYSE:DTC) and maintained a price target of $3.

Portfolio Pulse from Benzinga Newsdesk

September 30, 2024 | 3:31 pm

XOM

The options market shows a bullish sentiment towards Exxon Mobil (XOM), with 53% of trades being bullish. The price range focus is between $110 and $120. Analysts maintain positive ratings with target prices up to $149. XOM's stock is currently at $116.58, with a slight increase.

Portfolio Pulse from Benzinga Insights

September 30, 2024 | 3:30 pm

RCKT

Canaccord Genuity has reiterated its Buy rating for Rocket Pharmaceuticals, maintaining a price target of $38.

Portfolio Pulse from Benzinga Newsdesk

September 30, 2024 | 3:30 pm

AUR

Canaccord Genuity has reiterated its Buy rating for Aurora Innovation, maintaining a price target of $7.

Portfolio Pulse from Benzinga Newsdesk

September 30, 2024 | 3:28 pm

CMS

BMO Capital analyst James Thalacker maintains an Outperform rating on CMS Energy and raises the price target from $69 to $76.

Portfolio Pulse from Benzinga Newsdesk

September 30, 2024 | 3:28 pm